Home/ Supplements/ Omega 3/ Omega-3 2100 Natural Orange Flavor

Omega-3 2100 Natural Orange Flavor

product on market Softgel Capsule Oceanblue Professional Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Omega-3 fatty acid ethyl esters are supported by strong evidence for supporting cardiovascular health and managing triglyceride levels. These essential fats play a key role in maintaining cellular membrane integrity and reducing systemic inflammation. Research indicates these ingredients are generally safe for consumption when used as directed.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Omega-3 2100 Natural Orange Flavor
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
90
Servings
Fat/Fatty Acid
Product Type
20%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
25 Calorie(s)
Total Fat
2.5 Gram(s) (3% DV)
Cholesterol
10 mg (3% DV)
Protein
1 Gram(s)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

Omega-3 Marine Oil Capsule Shell natural Orange Oil natural Mixed Tocopherols
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Qualified Health
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: Take 1 or 2 softgels daily with meal.

Warnings & Precautions

Allergen Warning: Contains fish and soy derivatives.

Keep out of reach of children.

Do not use if safety seal is damaged or missing.

Formulation Notes

Why Omega-3 2100? We use a highly purified and concentrated blend of omega-3s and essential oils to provide our preferred ratio of EPA (eicosapentaenoic acid) to DHA (docosahexaenoic acid) to promtoe heart health. Our purity and concentration provides more omega-3s per softgel than other fish oil products.

Oceanblue Promise Traceability of our omega-3 oils back to their source. Transparency in our formulations and our labeling. Trust in our stewardship of the seas. Purity of our products to safeguard the health of your family.

Hg No detectable mercury

Supportive but not conclusive research shows that consumption of EPA and DHA omega-3 fatty acids may reduce the risk of coronary heart disease.

High-potency Heart Brain Eye Joint

2,100 mg omega-3 1350 mg EPA 600 mg DHA 150 mg DPA

Great tasting No burps

Additional Information

Manufactured in the USA

(90 day supply)

IFOS Friend of the Sea

Store in a cool dry place.

Metadata

Product Details

UPC / SKU8 50001 44929 8
DSLD Entry Date2021-11-19
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID256888
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.